Tailstorm Health INC

8 FDA enforcement actions

8 Total Recalls

0 Class I

8 Class II

0 Class III

Firm Details

Product Types: drug
States: AZ

All Recalls

Class II: Risk 06/02/2025 drug

Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.
Class II: Risk 06/02/2025 drug

Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.
Class II: Risk 06/02/2025 drug

Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.
Class II: Risk 06/02/2025 drug

Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.
Class II: Risk 06/02/2025 drug

Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.
Class II: Risk 06/02/2025 drug

Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.
Class II: Risk 11/06/2024 drug

Lack of Sterility Assurance
Class II: Risk 07/03/2024 drug

Subpotent Drug: reduced efficacy for epinephrine

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.